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Abstract
Background: Regardless of geography or income, effective help for depression and anxiety only reaches a small proportion of
those who might benefit from it. The scale of the problem suggests a role for effective, safe, anonymized public health–driven
Web-based services such as Big White Wall (BWW), which offer immediate peer support at low cost.
Objective: Using Reach, Effectiveness, Adoption, Implementation and Maintenance (RE-AIM) methodology, the aim of this
study was to determine the population reach, effectiveness, cost-effectiveness, and barriers and drivers to implementation of
BWW compared with Web-based information compiled by UK’s National Health Service (NHS, NHS Choices Moodzone) in
people with probable mild to moderate depression and anxiety disorder.
Methods: A pragmatic, parallel-group, single-blind randomized controlled trial (RCT) is being conducted using a fully automated
trial website in which eligible participants are randomized to receive either 6 months access to BWW or signposted to the NHS
Moodzone site. The recruitment of 2200 people to the study will be facilitated by a public health engagement campaign involving
general marketing and social media, primary care clinical champions, health care staff, large employers, and third sector groups.
People will refer themselves to the study and will be eligible if they are older than 16 years, have probable mild to moderate
depression or anxiety disorders, and have access to the Internet.
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Results: The primary outcome will be the Warwick-Edinburgh Mental Well-Being Scale at 6 weeks. We will also explore the
reach, maintenance, cost-effectiveness, and barriers and drivers to implementation and possible mechanisms of actions using a
range of qualitative and quantitative methods.
Conclusions: This will be the first fully digital trial of a direct to public online peer support program for common mental
disorders. The potential advantages of adding this to current NHS mental health services and the challenges of designing a public
health campaign and RCT of two digital interventions using a fully automated digital enrollment and data collection process are
considered for people with depression and anxiety.
Trial Registration: International Standard Randomized Controlled Trial Number (ISRCTN): 12673428;
http://www.controlled-trials.com/ISRCTN12673428/12673428 (Archived by WebCite at http://www.webcitation.org/6uw6ZJk5a)
(JMIR Res Protoc 2017;6(12):e231)   doi:10.2196/resprot.8061
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Introduction
Background
Unipolar depression and anxiety are the second and seventh
leading causes of years lived with disability in the world among
all health problems, respectively, according to the World Health
Organization [1]. The 12-month point prevalence of unipolar
depression, anxiety disorder, and mixed anxiety and depression
is 15% in the United Kingdom [2] and ranges from 4% to 20%
across 14 different developed and nondeveloped countries in
the world [3]. There are a number of reasons why a population
approach [4] to the management of depression and anxiety
employing supported self-management is required: (1) the scale
of the problem is too great both in terms of prevalence,
recurrence rates, and access to be met through primary care and
secondary care services alone, with only 33% of people
receiving any treatment in the United Kingdom with broadly
similar rates in developed countries in Europe and North
America and half these rates in less developed countries [3,5];
(2) people may choose not to seek professional help for a
number of reasons, including a preference for self-management,
fear of stigma, fear or lack of motivation resulting from anxiety
and depression, or as a result of having a previous bad
experience of mental health care [6,7]; (3) people may be unsure
where the boundary lies between their experience of stress on
the one hand or clinical anxiety and depression on the other [6],
sometimes preferring guidance before, or instead of, seeking
medical care; (4) people may prefer to manage their problems
themselves (personal empowerment) and at their own pace but
seek guidance and support when they choose [8,9]; (5) to combat
social isolation, people with depression and anxiety may
sometimes prefer to develop a social network of people who
are sympathetic to and understand what it is like to have
depression, anxiety, or related mental health problems [10,11];
and (6) primary and secondary care services largely manage
acute symptoms of anxiety and depression, focusing particularly
on depression as a common cause of suicidal behavior and may
not provide sufficient information and support for self-help to
prevent recurrence [12]. Public health interventions to manage
very common problems such as cigarette smoking, weight loss,
and diabetes care have increasingly utilized the Internet to reach
the public [13]. Provided safeguards are put in place to identify
and transfer care to primary and secondary care services when
appropriate (eg, high suicide risk), Internet programs offering
a range of tailored information and support might address all
or some of the six scenarios outlined above, among others.
Big White Wall (BWW) is a well-established digital service
(website and apps) being accessed by approximately 13,000
people in the United Kingdom in the past year. Currently, BWW
has been purchased by the armed forces, some universities, and
25% of clinical commissioning groups throughout England that
provide free access to 98% of the users. Only 2% of the users
are individuals who pay for the service through a £25 monthly
subscription. It is also available or being piloted in the United
States, Canada, Australia, and New Zealand.
BWW offers the following to people over the age of 16 years
[14]: (1) Web-based assessment to assess common mental health
problems and comorbid physical conditions; (2) moderated
online peer support network: a community of peers,
professionally staffed at all times, enabling safe, anonymous
support through talking therapies and creative self-expression;
(3) guided support: a range of self-managed and facilitated
programs for individuals and groups for depression and anxiety
and related issues such as sleep, smoking, and alcohol problems
based on cognitive behavioral therapy (CBT) and social support
principles; and (4) live therapy: a range of real-time therapies
by instant text, audio, or video from a panel of approved BWW
therapists offering CBT, interpersonal therapy, person-centered
counseling, or integrative counseling.
On the basis of public health principles, BWW emphasizes a
recovery model to improve well-being and is theoretically based
on a social model of depression emphasizing autonomy,
hopefulness, and support [14] (see [15] and [16] for reviews of
the social model of depression). There are no waiting lists,
eligibility criteria, or restricted opening hours (available 24/7).
Specially trained counselors employed by BWW as wall guides
facilitate interactions, ensuring that a culture of respect toward
others, tolerance, mutual learning, and safety are maintained at
all times. Mental well-being is seen as a systemic interplay of
factors that contribute to an individual’s engagement with
themselves, their social networks and communities, and the
society in which they live. Mental well-being is also seen as
being intimately connected with physical health and general
well-being.
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BWW offers guided self-help based on CBT principles, with
additional peer support—interventions that are recommended
as face-to-face interventions for mild to moderate depression
by the National Institute for Health and Care Excellence (NICE)
in England and Wales [12]. However, the randomized controlled
trial (RCT) evidence base for such interventions using a peer
social support model requires more extensive testing. Currently,
there is no RCT evidence that BWW is effective and only one
large previous RCT of Internet peer support in 311 people with
primary depression and anxiety [17]. This showed that both
Internet peer support and Internet peer support plus guided
self-treatment of depression (both of which BWW offers) versus
information about depression and anxiety alone, improved
depression and empowerment with additional benefits on quality
of life (QOL) and self-esteem in the combined intervention
[17,18]. The effects on empowerment were immediate, although
improvement in QOL was only apparent at 6 months. Peer
support was utilized more extensively than a formal course of
CBT. Furthermore, the study found that weekly contact with
the site was associated with greater improvements on ratings
of social support and loneliness. However, it is not a test of the
reach or effectiveness using the Reach, Effectiveness, Adoption,
Implementation (including economics) and Maintenance
(RE-AIM) methodology of a peer support program backed by
a public health campaign, unlike this study.
Moreover, BWW is a complex intervention that operates
differently to a psychological intervention in that people choose
exactly when and how they utilize it rather than commit
themselves to a course of treatment of a defined duration and
frequency, which may be restricted by external issues such as
clinician availability.
Peer support Internet interventions take less effort for service
users than Internet-guided CBT [18]. The involvement is usually
ongoing and unrelated to psychiatric crisis, for example, suicide
or self-harm, unlike crisis lines such as Samaritans. In principle,
relief from depression or anxiety can be achieved through BWW
by improving the quality and consistency of support [19]. The
effectiveness of BWW may be in keeping with the social model
of depression and anxiety on which it was conceived. The onset
of depression and anxiety is precipitated by the self-perception
of a potential or actual lasting and severe threat to the person's
well-being from a life event or a life difficulty in the absence
of social support (isolation) or insufficient social support [20].
Relief from depression or anxiety is achieved by improved
quality and consistency of support or life events that offer fresh
starts or increased security. People with personality dysfunction
may obtain less relief from depression and anxiety but still
benefit [21].
Thus, a person with depression and anxiety has access through
BWW to appropriate psychosocial support when they require
it. They are given guidance and are enabled to choose to
intervene in their own mental well-being (empowerment). This
early intervention approach may preempt the need for later
intervention if the person becomes worse. Although guided,
people are encouraged to make their own decisions on how to
use BWW so they retain their autonomy because perceived
control is thought to improve outcome in depression and anxiety
[15,16].
Alternatively, the National Health Service (NHS) has developed
a free website providing information on mental health conditions
and locally available resources called NHS Moodzone. It does
not provide anonymized moderated peer support.
The RE-AIM (model [22]), which is designed to enhance the
quality, speed, and public health impact of translational research
in a defined population, will be used as a framework for the
study. Here it will be used to compare free access to BWW
versus free access to information about depression and anxiety
from the NHS Choices Moodzone website for people who score
above depression or anxiety caseness in one area of England
serving inner city, urban and rural areas, and where there is no
current institutional or commissioned access to BWW.
The overall aim was to utilize a strategy that is broadly similar
to how BWW is usually implemented in a geographical area,
with clinical champions from primary care and service users
alongside publicity through local public health campaigns and
commissioners.
Objectives
The objectives for this study (known as “the REBOOT study”)
are bound within the RE-AIM framework:
Reach: To determine the number and representativeness of
participants invited and eligible to receive BWW or the NHS
Choices Moodzone website compared with the expected number
of participants (based on estimates from census data in the study
area).
Effectiveness: To determine the short-term clinical effectiveness
of randomization to BWW versus the Moodzone website on
well-being (primary outcome), depression symptoms, anxiety
symptoms, social function, and QOL in one locality over 3
months.
Adoption (by services): To determine the number, percent, and
representativeness of NHS primary care practices and
organizations, secondary care mental health, community and
acute trust, third sector, and social care organizations that
referred people to either BWW or the Moodzone website.
Implementation: To explore the implementation of the BWW
program, including barriers and drivers to reach, effectiveness
and adoption, and an economic evaluation of its costs and
cost-effectiveness from personal, social, and health care
perspectives.
Maintenance: To determine (1) The maintenance of treatment
effects on well-being, depressive symptoms, anxiety symptoms,
QOL, and social function over 6 months and (2) The take-up
by organizations and implementation (number, percentage of
BWW across the East Midlands) after the trial has been
completed.
We will also explore how the interventions may work by
quantitatively examining moderators and mediators of outcome
and conducting a qualitative analysis, and in the case of the
BWW intervention, discourse analysis.
The discourse analysis aims to answer the following research
questions:
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• How social support is provided within peer support
exchanges within BWW?
• What topics are discussed by trial participants when using
BWW?
Methods and Analysis
Trial Design
A single-blind, pragmatic RCT will be conducted in the county
of Nottinghamshire, United Kingdom using a fully automated
bespoke study website. Eligible participants, recruited through
self-referral methods such as social media, general practitioner
(GP) advertisements, and general marketing will be allocated
at random and without stratification to receive either 6 months
free access to BWW or be signposted to the NHS Moodzone
website. The primary outcome will be clinical effectiveness
(mental well-being) of BWW versus Moodzone as measured
by the 14-item Warwick-Edinburgh Well-being Scale [23,24]
from baseline, 3 to 6 weeks. Maintenance of effect at 12 and
26 weeks will be secondary outcome measures.
This RCT forms part of the East Midlands Collaboration for
Leadership in Applied Health Research and Care
(CLAHRC-EM), an applied health care research center funded
by the National Institute for Health Research (NIHR), the
Universities of Nottingham and Leicester, and over 50 partners
from health care, social care, and industry across the East
Midlands. Funded across the United Kingdom, there are 13
CLAHRCs that focus on the clinical and cost-effectiveness of
translational research that has been identified as priority areas
by local services. Service delivery studies of this kind, therefore,
require more than just the clinical outcomes that traditional
RCTs might produce and present the need to explore
cost-effectiveness, risk, adoption by services, reach, and the
barriers and drivers to implementation.
Ethical approval has been granted by the Local Research Ethics
Committee (REC 16/EM/0204), and final approval was received
from the Health Research Authority.
Recruitment
To optimize recruitment to the trial as well as the regional uptake
of BWW, a public health engagement campaign will run
alongside participant recruitment via local services to maximize
the opportunities for people without, as well as with current
access to mental health services, to take part in the trial. Potential
participants will all self-refer to the study website after accessing
information about the study via two main routes: (1) general
media and digital social media advertising and (2)
recommendation from health care professionals and other
support workers in NHS primary care, NHS secondary care,
social care, and third sector and community services.
Recruitment and adoption throughout the study will be closely
monitored and recorded in order that networks and reach can
be determined and analyzed.
Engagement Strategy
The public engagement strategy and recruitment to the study
will run in parallel with each other. The engagement strategy
will, for 1 month, publicize the study to NHS, local authority,
and third sector organizations in Nottinghamshire a month before
recruitment to the trial begins. The study will be integrated into
the early intervention stream of the Clinical Commissioning
Groups and Health and Well-being Board Mental Health
Strategy for Nottinghamshire. A range of methods will be used
to engage with potential study participants, including:
• Identification of primary care practices and other groups
of health professionals, for example, health visitors and
community pharmacists that are known to have an interest
in mental health and a willingness to adopt new
interventions early after their introduction in one part of
the county before moving to other parts
• Introducing a local general media advertising campaign
(eg, bus and tram adverts, newspapers, and radio), followed
by a Facebook and social media campaign
• Presenting the study to interested community groups,
targeting both the young (eg, further education colleges and
universities) and old (eg, Age UK), vulnerable groups (eg,
new parents living in disadvantaged areas, through
Surestart), third sector mental health groups (eg, Mind
branches in Nottinghamshire), and local organizations
promoting self-help (eg, Self-Help Nottingham)
• Producing online and offline presentations and written
materials
• Other novel approaches as they might arise in public health
and primary care, for example, public health message with
receipts in high footfall supermarkets or shopping centers
Patient and public involvement is central to the design and
delivery of this study. A user consultant has been appointed to
develop novel approaches and monitor, iterate, and evaluate the
effectiveness of the different engagement methods, with an
action-research type approach. The user consultant will develop
a lived experience advisory panel to help shape the study process
throughout. They will work with at least one GP knowledge
broker (who will act as clinical champions for the study as a
whole) in other areas where BWW has been implemented
successfully; this role has been important linking with GP and
other community health professionals and the early intervention
stream. Regular checks will show which methods are best for
broadening the reach of the study and BWW to a wider range
of people and groups and especially those isolated.
On the basis of 6- to 12-month engagement strategies using a
part-time engagement officer carried out by BWW in the West
Midlands (Dudley, Wolverhampton, and Walsall; in total a
similar size population to that of Nottinghamshire), 1950
participants (1.6% of the population) were recruited. We
anticipate a similar rate of recruitment in Nottinghamshire, with
approximately 2200 participants recruited to our study website
over a 12-month recruitment period, and we will have the
additional help of the user consultant and the public health
campaign publicizing the study.
The learning achieved from the recruitment period will inform
the best approaches to engage with the public in later stages of
the study. A feedback conference will engage with study
participants and other stakeholders groups (commissioners,
Improving Access to Psychotherapy services, public health, etc)
to enable understanding of the wider validity and relevance of
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emerging findings. An effective public dissemination strategy,
informed by our earlier learning, will communicate the findings
of the research to a wide audience to help mobilize the new
knowledge as part of the implementation strategy (see later
section).
Sample and Eligibility
Potential participants from the county of Nottinghamshire will
be able to self-refer, and their eligibility will be assessed by an
automated digital program on the study website. The study
website requests GP practice contact details in case the
participant is ineligible for the study.
The inclusion criteria are as follows:
• Aged 16 years or over
• Resident in the County of Nottinghamshire
• Scores between 10 and 20 on the 9-item Personal Health
Questionnaire (PHQ-9) [25] and/or 10 or more on the 7-item
Generalized Anxiety Disorder (GAD-7) questionnaire [26],
indicating probable caseness for depression and anxiety,
respectively, but not a definite diagnosis of depression or
anxiety disorder
• Access to the Internet through a computer, tablet, or
smartphone (Windows, iPhone operating system [iOS,
Apple Inc], and Android)
• Able and willing to give informed consent (through
electronic consent)
The exclusion criteria are as follows:
• Scores 21 or more on the 9-item Personal Health
Questionnaire (PHQ-9, severe depression)
• Scores 2 or 3 on PHQ-9 item “thoughts that you would be
better off dead or of hurting yourself in some way.”
• Scores below 10 on PHQ-9 and 7-item Generalized Anxiety
Disorder (GAD-7) questionnaire
• BWW and Moodzone are only available in English.
Therefore, the website will recommend to participants that
if they do not feel that they are sufficiently proficient in the
use of the English language, they need not take part. There
will be no test of proficiency.
Participants who are ineligible for the trial because they score
in the severe range on the PHQ-9 or signs of suicidality will be
provided with an opportunity to request that the study team
inform their GP, mental health care team, or carer of their current
mood state. If they choose not to take this offer, the study team
will follow this up on one occasion with an email to ask them
again if they would like the team to inform their GP or care
team. If they do not reply, the team will consider this
confirmation that they do not wish us to act on their behalf.
Participants that are under age will be given details of local
children’s mental health services. They will be informed that
they may return to the study website if they turn 16 years within
the recruitment period, should they still wish to participate.
Information for participants and the associated consent forms
are provided electronically within the study website. Participants
who wished to discuss the study could email and telephone the
study team if they had any further questions before consenting
to the study. An email confirming consent is sent to a participant
once they have fully enrolled in the study.
Expected Duration of Participant Participation
Participation in the study will be for 6 months (see Figure 1 for
participant journey through the study). Participants will receive
electronic follow-up invitations at 3, 6, 12, and 26 weeks after
randomization to be completed on the website. Participants may
also be asked to take part in a short interview by phone or
face-to-face to talk about their experiences of services and/or
the study no later than 3 months from the ending of their
participation.
Figure 1. Participants' journey through the study.
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Interventions
Randomization: Arm 1—BWW
Participants allocated to receive 6 months free access to the
BWW website will create a user profile using a pseudonym that
will be linked to the trial identification that they are assigned
within the study website. Participants will be able to access any
part of the BWW site (apart from the option of personalized
therapy or counseling sessions that have to be prescribed by a
clinician [ie, is not offered direct to the general public], and for
this reason it will not be accessible for participants in this study)
and interact with other users within the boundaries of the site’s
house rules. [14]. Anonymized records of log-ins, time on site,
interactions, and page categories will be recorded by BWW on
behalf of the study team.
Randomization: Arm 2—Participants Allocated to
Moodzone
Participants will be directed to the Moodzone area of the NHS
Choices website, a free to access website providing information
on mental health conditions and locally available resources.
Participants will be able to access all of the available material
on mental health, including depression and anxiety. The site
contains reading material and suggestions about maintaining
mental health and provides measures of depression and anxiety
for visitors to use.
All participants will be asked about whether they have received
or used any additional mental health resources during their time
in the study. NHS Moodzone access is used as the control digital
resource so that all the participants are offered some help for
their problems with depression or anxiety, but the control group
do not access moderated, anonymized peer social support.
Outcome Measures
Once consented, participants will be asked to complete self-rated
questionnaires to measure well-being, depression, anxiety, work
and social adjustment, QOL (for economic analysis), receipt of
services (for economic analysis), social support, and personality
dysfunction (see Table 1). These will be completed online
(through the study website) in approximately 20 to 30 min, with
the primary outcome data collected first. All data will be stored
on the website and downloaded and anonymized by the clinical
trials manager.
Primary Outcome Measure
• Change in self-rated well-being at from baseline to 3 and
6 weeks after baseline using the 14-item
Warwick-Edinburgh Mental Well-Being Scale (WEMWBS)
Secondary Outcomes Measures
• Maintenance of well-being 12 and 26 weeks using the
WEMWBS
• GAD-7 scale—completed as part of eligibility at baseline
and then at 3, 6, 12, and 26 weeks as a brief measure of the
severity of 7 symptoms of anxiety
• PHQ-9—completed as part of eligibility at baseline and
then at 3, 6, 12, and 26 weeks as a measure of depression
severity according to the Diagnostic Statistical Manual,
4th edition criteria [27]
• 12-item Medical Outcomes Study Short Form health survey
version 2.0 (SF-12v2) [28]—a short and practical measure
of health-related QOL derived from the longer SF36 that
is obtained during interview
• Social support is measured using the 8-item Medical
Outcomes Study Social Support Survey (MOS-SS) [29],
and it is completed at baseline
• Social function on the 8-item Work and Social Adjustment
Scale (WSAS) [30]—a simple measure of impact on
function, which is attributable to a particular cause such as
depression or anxiety. It is completed at baseline and then
at 3, 6, 12, and 26 weeks
Mediators of the effectiveness of BWW compared with
Moodzone on mental well-being might be the emotional and
informational support subscales of the MOS-SS [29]. Data
collected by BWW suggest that perceived social support might
be an important mediator of outcome, particularly in people
experiencing life events and loneliness.
Moderators of outcome at baseline might be the presence of life
events in the previous 6 months, measured by the 12-item
Brugha Inventory of Life Events [31], and the presence of
anxiety alone at baseline. Personality dysfunction will be
measured at baseline using the 8-item Standardised Assessment
of Personality-Abbreviated Scale (SAPAS) [32]. There may be
an interaction between the presence of life events at baseline
and greater perceived emotional support from BWW at 3 months
and on mental well-being at 6 months, whereas higher scores
on the SAPAS may predict dropout and little difference between
the treatment arms on mental well-being at 6 weeks.
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Table 1. Timing and delivery of outcome measures.
26 weeks12 weeks6 weeks3 weeksBaselineMeasure
WebsiteWebsiteWebsiteWebsiteWebsiteWEMWBSa
WebsiteWebsiteWebsiteWebsiteWebsitePHQ-9b
WebsiteWebsiteWebsiteWebsiteWebsiteGAD-7c
WebsiteWebsiteWebsiteWebsiteWebsiteWSASd
XXXXfWebsiteMOS-SSe
XXXXWebsiteSAPASg
XXXXWebsiteBrugha Lifeh
InterviewXXXWebsiteSF12-v2i
InterviewXXXWebsiteCSRIj
aWEMWBS: Warwick-Edinburgh Mental Well-Being Scale.
bPHQ-9: 9-item Personal Health Questionnaire.
cGAD-7: 7-item Generalized Anxiety Disorder Scale.
dWSAS: Work and Social Adjustment Scale.
eMOS-SS: 8-item Medical Outcomes Study Social Support Survey.
fX: Measures are not collected at this time point.
gSAPAS: Standardised Assessment of Personality-Abbreviated Scale.
hBrugha Life: 12-item Brugha Inventory of Life Events.
iSF-12v2: Medical Outcomes Study Short Form health survey version 2.0.
jCSRI: Client Service Receipt Inventory.
To explore the reach, adoption, and implementation arms of the
RE-AIM framework, a number of process measures will be
recorded as the study progresses:
• Live log of services, individuals, groups, and charities that
are approached to engage with the study. The networks that
surround these and how this may spread will be recorded
and used to determine reach and adoption. A network of
practice comprising all health care stakeholders will be
established to explore implementation pathways.
• Reach will be further explored using Internet analytic
software or to derive anonymous data around hit and bounce
rates, pages visited, length of visit, type of geography, and
simple demographics to the study website can be recorded,
downloaded, and analyzed
• Implementation will be explored when highlighting the
barriers and drivers to reach, effectiveness, and adoption
assessed through qualitative work with the services, groups,
and individuals engaged through recruitment, as well as an
economic evaluation of its costs and cost-effectiveness from
personal, social, and health care perspectives. In particular,
we will explore how participants utilize BWW in relation
to the literature on similar websites offering peer support
and information for physical illness and literature on social
and organizational aspects of depression and anxiety care.
• Working with the local Academic Health Science Network
to record the take-up by organizations and implementation
(number, percentage, and representativeness in East
Midlands) of BWW across the East Midlands after the trial
has been completed should it prove to be clinically and cost
effective.
In terms of socioeconomic inequalities, we will record the
following provided such detailed recording of information does
not deter participation: postcode, age, gender, ethnicity marital
status, highest level of education, and employment.
Sample Size and Justification
Given that the focus of BWW is on improving mental well-being
rather than specifically depression or anxiety, a clinically
important difference on the WEWBS was selected as the primary
outcome. Data from BWW online support groups show clinically
important differences in depression by 6 weeks, so the primary
outcome will be a change in the WEWBS from baseline to 3
and 6 weeks. The minimal clinically important difference
(MCID) for adults on the 14-item WEWBS with mild to
moderate depression and anxiety is 3 points and WEWBS scores
are normally distributed [24]. On the basis of data from a
Web-based CBT intervention versus information from an RCT
in a similar participant group with a similar design [33], and
inflating the variance (to allow for contamination) at 6 weeks
by almost 50%, we estimate the sample size required to detect
a 3-point MCID between the BWW and Moodzone groups at
6 weeks to be 676 in total or 338 per treatment group using the
analysis of covariance method with 90% power to show a
difference at two-sided 5% significance level assuming zero
correlation between pre- and posttreatment outcomes. In the
previous study, the intervention and control groups were 42.20
(standard deviation [SD] 9.83) and 42.32 (SD 9.64),
respectively, and by 6 weeks they were 44.46 (SD 8.1) and
41.92 (SD 9.18). In the power calculation, we have assumed
that at baseline, each intervention group will have a mean
baseline score of 42.20 (SD 9.83) and that this will increase to
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44.46 (SD 12.0) in BWW and fall slightly to 41.46 (SD 12.0)
in the Moodzone control group at 6 weeks. There are no data
currently available using the WEWBS with BWW, but BWW
online support groups show a drop in PHQ-9 score from 13.9
(SD 7.1) to 8.6 (SD 6.5) at 6 weeks—a change that is equal to
an MCID of 5.0 points suggesting that BWW can produce
clinically important differences in outcome.
The analysis will use multilevel modeling because of repeated
measures in the same individuals. People directly participate in
the study so there is no other form of clustering operating in
this study. Our power calculation performed has already taken
into consideration clustering because of repeated measures.
Assuming a 50% loss to follow-up, a total of 1352 participants
are required for the RCT [33,34] but typically BWW would be
expected to enroll 2200 people in a county the size of
Nottinghamshire if the uptake of BWW was consistent with the
general pattern seen in similar parts of the country. Furthermore,
in a study with a similar design [33], 3070 (63.52%, 3070/4833)
participants who were enrolled into the study completed
eligibility criteria on a website and were invited to take part.
Taking a conservative approach, we would recruit approximately
1400 participants out of 2200 people meeting eligibility criteria
and enrolling onto the study site. This would be sufficient to
recruit an adequate sample size. Stata 14 (StataCorp LLC, USA)
was used to perform power analysis [35].
Randomization and Monitoring
The treatment to which a participant is assigned will be
determined by a computer-generated pseudorandom code using
random permuted blocks of varying size by a randomization
system embedded within the website. No stratification or
minimization is required. The outcome will be single-blind with
the clinical trials manager and research associates responsible
for the collection, cleaning, and analysis of the data remaining
blind to arm allocation until data collection has been completed.
Cases of unblinding will be recorded electronically but will not
be excluded. Unblinding will only be necessary upon completion
of data collection.
Overall, trial monitoring and oversight will be carried out by
the CLAHRC-EM Scientific Committee who will act as the trial
steering committee and data monitoring committee. The
CLAHRC-EM scientific committee is composed of independent
experts in statistics, epidemiology, medicine, and patient and
public involvement. They will be sent quarterly reports on the
status of the study and have the power to recommend or
implement changes to the protocol if necessary. They are also
able to stop the study if it is deemed unsafe or is failing to recruit
after all avenues to recruitment have been exhausted.
There is no planned assessment of safety within the study design,
and unless participants report any intercurrent illness or adverse
events directly to the study team, it is unlikely that these can be
recorded systematically.
Statistical Analysis
Analysis of the primary and secondary outcome measure data
will be carried out by the trial statistician, who will remain blind
to arm allocation, using STATA 14.
In a RE-AIM study, all outcomes are considered to address
important facets of a public health intervention. Therefore, we
will examine reach (the percentage and representativeness) of
participants entering the trial. Exploratory analysis will
summarize outcome variables and participant background
variables by treatment arms across follow-up time with mean
(SD) for normally distributed data, median (interquartile range)
for skewed variables, and frequency (percentage) for observed
level of categorical variables. The analysis to examine the
treatment effect will be performed on an intention-to-treat basis.
As the primary outcome WEWBS score will be repeatedly
measured at baseline, 3 weeks, and 6 weeks, multilevel modeling
will be performed to quantify the treatment effect with
participant as a level 2 unit and baseline measurement as a
covariate using Stata 14. Missing values will be imputed using
a multiple imputation approach under a missing at random
assumption. Path analysis will be used to explore changes in
perceived emotional social support and empowerment at 3 weeks
as potential mediators for treatment effects on mental well-being
at 6 weeks, alongside life events, loneliness, having a partner,
gender, age, anxiety without depression, and personality
dysfunction at baseline as possible moderators for treatment
effect. Such information will provide important information to
refine both the targeting and content of BWW to optimize its
reach and effectiveness.
A detailed statistical analysis plan setting out full details of the
proposed analyses will be finalized before the trial database is
locked for final analysis. Stata 14 will be used to perform
exploratory data analysis and multilevel modeling, Mplus
software (Muthen & Muthen, USA) will be used to perform
path analysis [36].
Adoption and Implementation
Adoption will be examined according to the prevalence of
uptake and promotion of the study by primary care, secondary
care, social care, and third sector organizations. Implementation
will be examined in four ways: (1) a quantitative analysis of
patterns of acute use of BWW from baseline to 6 weeks
according to clinical and sociodemographic factors; (2) an
economic evaluation; (3) long-term effects will also be explored
using qualitative interviews and patterns of use of data from the
websites. An analysis of barriers and drivers of participants,
public and patient groups, and health professionals to reach,
adoption, effectiveness, and maintenance of BWW using
digitally recorded and thematically analyzed individual
qualitative interviews; and (4) textual analysis of written
comments made by participants and qualitative interviews to
explore the process of self-management, peer support, and
organization of care on BWW.
Health Economics
The study will be conducted from an NHS and societal
perspective, which will include cost to the individual but will
in addition to clinical outcomes measure the participant's own
health status using the SF12-v2 during participant interviews
[28]. Thus, the study results will be reported in terms of
cost-effectiveness and cost-utility. A detailed resource profile
will be established for the intervention versus usual care. The
resource profile will include capital costs, for example, the
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technology, licensing agreements, and assumptions around the
length of life of the respective Internet technologies and
participant costs in each arm (eg, time accessing the Internet).
Economic data will be collected using the economic resource
proforma (the Client Service Receipt Inventory [37]), which
was piloted successfully in a previous study [38]. Economic
data around service use will be collected at baseline, and further
economic data, including any time lost from work or usual
activities, will be collected during interviews with 200
participants at 12 and 26 weeks who consent to be interviewed.
Medication costs will be obtained from the British National
Formulary, primary care contacts assigned using community
and hospital-based costs from NHS reference costs. Information
collected from participants will include any time lost from work
or usual activities. An incremental cost-effective ratio and
cost-effectiveness acceptability curves will be produced for the
BWW versus Moodzone sites. This use of this probabilistic
analysis is recommended in NICE guidelines and is
economically more useful than classical probability estimates
of significance.
Qualitative Analysis
Qualitative interviewing and analysis will be used to determine
the barriers and motivations for participant engagement in the
study to inform and further develop the study’s engagement
strategy. We also intend to explore participants’ experiences of
taking part in the study to gain and understand the motivations
for use of online peer support. For those in the BWW arm of
the study, this will include patterns and levels of engagement
(eg, active user vs “lurker”), negative experiences and beliefs
about efficacy, and role in personal empowerment. For those
in the Moodzone arm, we will interview participants about
negative and positive experiences of receiving just information
in relation to managing depression and anxiety. Qualitative
interviews will be sought with a maximum variance sample
based on sociodemographic factors, scores on baseline clinical
measures, and whether or not they are using other health
services. Participants will be contacted after they have been in
the study for 6 weeks. We will also interview those who did not
wish to participate or dropped out but indicated they wished to
be contacted to leave feedback.
Participant Messages
All conversation threads over 6 months in which at least one
message has been posted by a trial participant will be retrieved
by BWW and sent securely and anonymously to the research
team. These will include messages posted by nonstudy
participants. However, these messages will not be analyzed;
rather they are provided to understand the context of the
messages posted by the study participants.
The data generated for this phase will be analyzed using content
analysis [39]. This approach is frequently used to quantify
theoretical concepts and qualitative data categories in the
manifest content of large volumes of textual information and
has been successfully employed in previous studies [40-42].
We will address the discourse analysis questions as follows:
How social support is provided within peer support exchanges
within BWW?
We propose to employ the Social Support Behavior Code [43]
as our guiding theoretical framework. This framework has been
used extensively in the analysis of online forum communication
(eg, [43]) and provides the means to identify and quantify the
presence of five key categories of social support: information
support, emotional support, network support, esteem support,
and tangible assistance. Our analysis will record separately the
number of requests for support as well as the provision of
support, by category (above), within the dataset.
What topics are discussed by trial participants when using
BWW?
We propose to use thematic analysis to address this research
question using previous guidelines [44]. This approach allows
the systematic analysis of textual data to identify and describe
emergent themes based on patterns within the dataset.
Discussion
Only 33% of people with depression or anxiety receive any help
from health services in England [5] and other developed
countries in Europe and North America [3]. Public-facing
websites, such as BWW, offering support and help may offer
effective help delivered at scale to very large populations. Yet,
the effectiveness of BWW has yet to be established, and our
study will provide the first rigorous test of this.
The design of such a large automated study in one geographical
area poses a number of methodological challenges, and our
study design has a number of strengths as well as inevitable
weaknesses.
Strengths
The pragmatic design of the trial means that our estimates of
effectiveness and cost-effectiveness are likely to be generalizable
to other areas of the United Kingdom and other high income
populations as this is a direct to the public study that does not
rely on health service infrastructure that varies from place to
place.
The public health (RE-AIM) approach of the REBOOT study
will help to raise awareness of the possibility of digital
intervention with a large group of people with depression and
anxiety who are not currently engaged with primary care or
mental health services. It will also explore whether it provides
additional help to those who are already engaged with these
services in relation to immediate moderated anonymized support
and digital approaches to socialization and recovery that might
be more convenient and approachable than comparable
face-to-face approaches. It will provide a great deal of
information surrounding the reach and adoption of such a
resource and the role it plays in their well-being. We will know
the clinical, sociodemographic, and health care service use of
participants and visitors to the site who complete baseline
information but decide not to be randomized as well as those
who utilize the interventions, and completers and dropouts from
the study. We will also be able to explore through process
evaluation moderators and mediators of mental well-being
through both treatment arms and in more detail in the BWW
treatment arm by detailed quantitative and qualitative analysis
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of social messaging through BWW. Therefore, there is the
opportunity through such process evaluation to improve the
reach or effectiveness of digital interventions such as BWW
and also to predict more clearly what the impact of BWW might
be in an area outside Nottinghamshire if such services were
commissioned [45]. The protocol is ambitious, but the feasibility
of conducting a fully mobile randomized clinical trial for
depression has been demonstrated recently with the
randomization of 626 participants [46].
Limitations
Therefore, we have carefully coproduced the REBOOT study
website with e-mental website developers such as M-Habitat
[47] and the lived experience of the Lived Experience Advisory
Panel of service users, who have also contributed to the public
health campaign, to reflect the experience of people of different
ages, gender, and sociodemographic background with personal
experience of depression and anxiety. By doing so, we hope
that the REBOOT public health campaign and study website
will engage and connect with people who have depression and
anxiety in the community so that they will enter the study and
continue in follow-up. We have also considered issues of
intrinsic reward (eg, altruism, motivational statements, and
feedback on completion) and extrinsic reward (reminders
through text, email, and entry of completers into competitions)
to encourage completion of data on the website at each time
point [48]. Issues around access to the Internet, ownership of
devices, and having access and competence with information
technology may also be barriers to the use of the interventions
that will be explored through qualitative interviews.
A further complication in the digital study is the issue of
contamination. People with depression or anxiety might access
BWW or Moodzone independently, although in the county of
Nottinghamshire the opportunity to enroll in BWW is limited
to access through the Armed Forces as new personal subscription
has been suspended for the duration of recruitment and
follow-up in the REBOOT study. Only one randomization is
possible from each web browser within a 30 day period.
Participants may be able to deceive the randomization process
through access from a different computer or web browser or by
clearing the cookie installed to prevent multiple attempts.
Internet protocol (IP) address was not used as a marker to
prevent multiple randomizations in case several people might
be sharing the same computer. There may also be potential
leakage with people who live outside Nottinghamshire using
work postcodes that are within the county. Furthermore, there
are potential problems with contamination through digital users
utilizing alternative sources of digital support and information
rather than the study treatment allocated to them. For instance
people might join Facebook and offer support to each other
even though it is not anonymized, and there is no profession
moderation or support. If any of these occurred to a significant
extent, it may be difficult to show real improvements in clinical
and cost-effectiveness. To understand these potential sources
of contamination, we are asking all participants about use of
other sites.
The design of studies to evaluate the reach, adoption,
clinical-effectiveness, and cost-effectiveness of direct to the
public digital health interventions for mental health problems
are important, given the reach, popularity, and low cost of such
approaches in a world that is increasingly digitally connected
even in the poorest countries of the world. However, we are in
the early stages of understanding how to optimally design such
studies.
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SD: standard deviation
SF-12v2: Medical Outcomes Study Short Form health survey version 2.0
WEMWBS: Warwick-Edinburgh Mental Well-Being Scale
WSAS: Work and Social Adjustment Scale
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